Emergence of the Delta Plus variant of SARS-CoV-2 in Iran

Farid Rahimi; Amin Talebi Bezmin Abadi

doi:10.1016/j.genrep.2021.101341

Emergence of the Delta Plus variant of SARS-CoV-2 in Iran

Farid Rahimi, Amin Talebi Bezmin Abadi^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

13 Citations (Scopus)

Abstract

The COVID-19 incidence rose potentially alongside the emergence of the SARS-CoV-2 Delta Plus variant in Iran. Genomic efforts like that of COG in UK are required in other countries, particularly in low-income and middle-income countries. National and international mass vaccinations and extant countermeasures are critical for curbing the pandemic.

Original language	English
Article number	101341
Journal	Gene Reports
Volume	25
DOIs	https://doi.org/10.1016/j.genrep.2021.101341
Publication status	Published - Dec 2021

Access to Document

10.1016/j.genrep.2021.101341

Cite this

@article{847b296998994306bd75309df9e57e73,

title = "Emergence of the Delta Plus variant of SARS-CoV-2 in Iran",

abstract = "The COVID-19 incidence rose potentially alongside the emergence of the SARS-CoV-2 Delta Plus variant in Iran. Genomic efforts like that of COG in UK are required in other countries, particularly in low-income and middle-income countries. National and international mass vaccinations and extant countermeasures are critical for curbing the pandemic.",

keywords = "B.1.1.7/VUI-202012/12, B.1.351/501YV-2, COVID-19, Delta plus SARS-CoV-2 variant, K417N mutation, Mutation, Pandemic, Vaccine",

author = "Farid Rahimi and {Talebi Bezmin Abadi}, Amin",

year = "2021",

month = dec,

doi = "10.1016/j.genrep.2021.101341",

language = "English",

volume = "25",

journal = "Gene Reports",

issn = "2452-0144",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Emergence of the Delta Plus variant of SARS-CoV-2 in Iran

AU - Rahimi, Farid

AU - Talebi Bezmin Abadi, Amin

PY - 2021/12

Y1 - 2021/12

N2 - The COVID-19 incidence rose potentially alongside the emergence of the SARS-CoV-2 Delta Plus variant in Iran. Genomic efforts like that of COG in UK are required in other countries, particularly in low-income and middle-income countries. National and international mass vaccinations and extant countermeasures are critical for curbing the pandemic.

AB - The COVID-19 incidence rose potentially alongside the emergence of the SARS-CoV-2 Delta Plus variant in Iran. Genomic efforts like that of COG in UK are required in other countries, particularly in low-income and middle-income countries. National and international mass vaccinations and extant countermeasures are critical for curbing the pandemic.

KW - B.1.1.7/VUI-202012/12

KW - B.1.351/501YV-2

KW - COVID-19

KW - Delta plus SARS-CoV-2 variant

KW - K417N mutation

KW - Mutation

KW - Pandemic

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85118694278&partnerID=8YFLogxK

U2 - 10.1016/j.genrep.2021.101341

DO - 10.1016/j.genrep.2021.101341

M3 - Letter

SN - 2452-0144

VL - 25

JO - Gene Reports

JF - Gene Reports

M1 - 101341

ER -

Emergence of the Delta Plus variant of SARS-CoV-2 in Iran

Abstract

Access to Document

Other files and links

Fingerprint

Cite this